| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2016PLoSO..1164908G |
| P356 | DOI | 10.1371/JOURNAL.PONE.0164908 |
| P932 | PMC publication ID | 5072601 |
| P698 | PubMed publication ID | 27764157 |
| P50 | author | András Jakab | Q42838214 |
| Gerald Maurer | Q47504475 | ||
| Mariann Gyöngyösi | Q63389907 | ||
| Julia Mascherbauer | Q64966998 | ||
| Noemi Pavo | Q87725470 | ||
| Irene M Lang | Q87931178 | ||
| Jutta Bergler-Klein | Q91330593 | ||
| Senta Graf | Q96836054 | ||
| Silvia Charwat | Q117250349 | ||
| Heinz Sochor | Q117250350 | ||
| P2093 | author name string | Márta Sárközy | |
| Abelina Zimba | |||
| Beatrice Marzluf | |||
| Bonni Syeda | |||
| Georgiana-Aura Giurgea | |||
| MYSTAR investigators | |||
| P2860 | cites work | Adult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled Trials | Q28082162 |
| Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) | Q28216990 | ||
| Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data | Q30896351 | ||
| Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction | Q30968626 | ||
| Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial | Q31033745 | ||
| Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial | Q33505911 | ||
| Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy | Q33919886 | ||
| Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes | Q34288961 | ||
| Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial | Q34332467 | ||
| Meta-analysis of cell therapy trials for patients with heart failure | Q35551127 | ||
| Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up | Q37305343 | ||
| Diagnostic and prognostic value of 3D NOGA mapping in ischemic heart disease | Q37876676 | ||
| Incidence and predictors of appropriate therapies delivered by the implantable cardioverter defibrillator in patients with ischemic cardiomyopathy: a systematic review | Q38275550 | ||
| Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials | Q39222871 | ||
| Sequential (201)Tl imaging and dobutamine echocardiography to enhance accuracy of predicting improved left ventricular ejection fraction after revascularization | Q44018265 | ||
| The effects of intracoronary delivery of mononuclear bone marrow cells in patients with myocardial infarction: a two year follow-up results. | Q44322392 | ||
| Extent of RV dysfunction and myocardial infarction assessed by CMR are independent outcome predictors early after STEMI treated with primary angioplasty | Q44933221 | ||
| Effect of intramyocardial delivery of autologous bone marrow mononuclear stem cells on the regional myocardial perfusion. NOGA-guided subanalysis of the MYSTAR prospective randomised study. | Q51729035 | ||
| Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study. | Q51804556 | ||
| Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. | Q53638713 | ||
| Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial | Q56610959 | ||
| Sustained improvement in left ventricular function after bone marrow derived cell therapy in patients with acute ST elevation myocardial infarction | Q57786207 | ||
| Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study | Q58071326 | ||
| Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: A multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocar | Q58071404 | ||
| The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure | Q59187009 | ||
| The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure | Q62023655 | ||
| Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-year follow-up results of the Myocardial Regeneration and Angiogenesis in My | Q79615200 | ||
| Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction | Q79827049 | ||
| NOGA-guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A-165 in patients with chronic myocardial ischemia: subanalysis of the EUROINJECT-ONE | Q81208164 | ||
| Five-year results of intracoronary infusion of the mobilized peripheral blood stem cells by granulocyte colony-stimulating factor in patients with myocardial infarction | Q84825127 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0164908 | |
| P577 | publication date | 2016-10-20 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Long-Term Outcome of Combined (Percutaneous Intramyocardial and Intracoronary) Application of Autologous Bone Marrow Mononuclear Cells Post Myocardial Infarction: The 5-Year MYSTAR Study | |
| P478 | volume | 11 |
| Q49908120 | EGFP transgene: a useful tool to track transplanted bone marrow mononuclear cell contribution to peripheral remyelination. |
| Q61804735 | Rationale and design of a prospective, randomised study of retrograde application of bone marrow aspirate concentrate (BMAC) through coronary sinus in patients with congestive heart failure of ischemic etiology (the RETRO study) |
| Q64230050 | Therapeutic effects of adipose derived fresh stromal vascular fraction-containing stem cells versus cultured adipose derived mesenchymal stem cells on rescuing heart function in rat after acute myocardial infarction |
Search more.